Adaptimmune Therapeutics

0.52
-0.02 (-3.70%)
At close: Mar 03, 2025, 3:59 PM
0.51
-2.46%
After-hours: Mar 03, 2025, 04:00 PM EST

Adaptimmune Therapeutics Cash Flow Statement

Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13
Net Income -113.87M -165.46M -158.09M -130.09M -137.16M -95.51M -70.14M -71.58M -23.69M -14.37M -9.34M
Depreciation & Amortization 9.45M 6.08M 6.57M 7.59M 8.01M 7.81M 5.42M 3.29M 732.78K 250.37K 45.6K
Stock-Based Compensation 11.77M 18.24M 20.63M 10.41M 11.05M n/a 10.8M 8.82M 4.22M 349.15K 170.26K
Other Working Capital -25.05M -1.53M 134.63M 56.05M 4.72M -45.34M 7.21M 12.5M -13.74M 49.78M 904.52K
Other Non-Cash Items -23.19M 903K 1.17M -55K -185K 237K 341K -1.19M -257.89K 1.7K 457.58K
Deferred Income Tax n/a n/a 5.82M 2.5M 1.06M 12.22M -7.95M n/a n/a 1.22M -0.00
Change in Working Capital -25.05M -1.53M 134.63M 56.05M 4.72M -45.34M 7.21M 12.5M -13.74M 49.78M 904.52K
Operating Cash Flow -140.88M -141.77M 10.73M -53.59M -112.51M -104.39M -54.31M -48.17M -32.74M 37.23M -7.77M
Capital Expenditures -4.88M -29.74M -8.78M -2.91M -3.07M -4.71M -25.01M -12.79M -5.11M -1.45M -159.62K
Acquisitions 45.26M 77.86M 207K 565K 1.48M 798K 369K 1.28M n/a n/a n/a
Purchase of Investments -75.95M -48.12M -139.76M -381.04M -27.28M -150.79M -171.33M -42.84M -55.3M n/a n/a
Sales Maturities Of Investments 210.98M 166.99M 224.34M 105.02M 125.3M 138.04M 69.72M 73.38M n/a n/a n/a
Other Investing Acitivies 925K -77.86M -207K -565K -1.48M -798K 181K -1.28M 124.23K n/a n/a
Investing Cash Flow 176.54M 89.14M 75.8M -278.92M 94.94M -17.46M -126.08M 17.75M -60.28M -1.45M -159.62K
Debt Repayment n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -1.29M
Common Stock Repurchased n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies 256K 50K 759K 5.66M 366K 102.69M 401K 17K 175.99M -159.05M -10.81M
Financial Cash Flow 880K 12.87M 3.29M 340.05M 366K 102.69M 103.57M 17K n/a 16.94M 3.71M
Net Cash Flow 37.41M -42.06M 90.18M 6.58M -17.57M -15.82M -74.5M -35.98M 181.72M 52.72M -4.22M
Free Cash Flow -145.76M -171.51M 1.95M -56.5M -115.58M -109.1M -79.33M -60.95M -37.85M 35.78M -7.92M